
Manuel Torralba is involved in projects within Biocat's Scaling and Access Area, such as ATMP Catalonia and INNOPASS, as well as European initiatives including BRIDGE and PRECISEU. Previously, he spent five years conducting research on hereditary cancer at IDIBELL, where he specialized in stem cell-based models, gene editing and precision diagnostics. He holds a degree in Biotechnology, a master's degree in Healthcare Biotechnology from Pablo de Olavide University (Seville), and a PhD in Biomedicine from the University of Barcelona.
He stands out for his interpersonal skills, teamwork and resilience. Outside of work, he enjoys rock climbing, spending time in the mountains and actively participating in cultural initiatives such as the Muixeranga de Barcelona.
